← Back to Search

Intervention for Exercise (Conmigo Trial)

N/A

Waitlist Available

Led By Elva M Arredondo, PhD

Research Sponsored by San Diego State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

Conmigo Trial Summary

This trial will test whether a 12-week virtual intervention can increase physical activity among Latina pre-adolescent girls and their mothers.

Eligible Conditions

Exercise
Female
Hispanic Americans
Children

Conmigo Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in daughters' Moderate to Vigorous Physical Activity (objective) from baseline (M1) to post-intervention (M2 at 3 months).

Change in daughters' Moderate to Vigorous Physical Activity (self-report) from baseline (M1) to post-intervention (M2 at 3 months).

Sustainment of daughters' Moderate to Vigorous Physical Activity (self-report) at M3 (6 months)

Secondary outcome measures

Change in mothers' Moderate to Vigorous Physical Activity (objective) from baseline (M1) to post-intervention (M2 at 3 months).

Change in mothers' Moderate to Vigorous Physical Activity (self-report) from baseline (M1) to post-intervention (M2 at 3 months).

Mother-daughter communication

+2 more

Conmigo Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Conmigo PA InterventionExperimental Treatment1 Intervention

12-week program (90 minutes/week)

Group II: Delayed Abbreviated InterventionActive Control1 Intervention

No intervention during experimental phase; participants in control group receive abridged program after the final measurement point (wait list control).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intervention

2011

Completed Phase 4

~73780

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

San Diego State UniversityLead Sponsor

152 Previous Clinical Trials

86,231 Total Patients Enrolled

Elva M Arredondo, PhDPrincipal InvestigatorSan Diego State University

1 Previous Clinical Trials

436 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must individuals meet in order to qualify for involvement in this research?

"This investigation has a target enrollment of 180 people who have offspring and are between 8 and 65 years old."

Answered by AI

Are there still opportunities to volunteer for this clinical trial?

"Correct. According to clinicaltrials.gov, this medical study is currently looking for patient participants and has been in search of them since February 11th 2021. The last time information about the trial was updated was on October 31st 2022, when it became known that 180 volunteers were needed from 1 site."

Answered by AI

How many participants have been enrolled in this clinical experiment?

"That is correct. According to records on clinicaltrials.gov, the experiment was initially published on February 11th 2021 and was most recently updated October 31st 2022; it seeks 180 participants from one site."

Answered by AI

What are the objectives of this experiment?

"This experiment will monitor the Change in Moderate to Vigorous Physical Activity (MVPA) of both mothers and daughters over a 6 month period. Additional objectives are Sustainment of MVPA at 3 months after the intervention, and assessment of mother-daughter communication through surveys. Data collection tools include an ActiGraph wGT3X accelerometer for Objective PA data, Global Physical Activity Questionnaire (GPAQ), and Parent-Adolescent Communication Scale (PACS)."

Answered by AI

Is the age requirement for this trial limited to those under sixty years old?

"This trial is only open to those aged 8-65. Those too young or elderly for the study can consult 54 and 69 alternative clinical trials, respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Conmigo: A Mother-daughter Intervention to Promote Physical Activity

Elva Arredondo 2021. "Conmigo: A Mother-daughter Intervention to Promote Physical Activity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04736030.